Cell Press

SHERPA: Unknown

People

  1. Offit
    Offit
  2. Rudin
    Rudin
  3. Solit
    Solit
  4. Rosen
    Rosen
  5. De Stanchina
    De Stanchina
  6. Robson
    Robson
  7. Chandarlapaty
    Chandarlapaty
  8. Schultz
    Schultz
  9. Norton
    Norton
  10. Berger
    Berger

Groups

  1. Department of Medicine (270)
  2. Solid Tumor Oncology Division (270)
  3. GSK Faculty (211)
  4. Sloan Kettering Institute Postdocs (111)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (92)
  6. Human Oncology and Pathogenesis Program (83)
  7. Breast Medicine Service (71)
  8. Sloan Kettering Institute Faculty (69)
  9. Department of Pathology and Laboratory Medicine (61)
  10. Genitourinary Oncology Service (61)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (202)
  2. Editorial (26)
  3. Meeting Abstract (24)
  4. Review (11)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Miscellaneous (2)
Groups
  1. Department of Medicine (270)
  2. Solid Tumor Oncology Division (270)
  3. GSK Faculty (211)
  4. Sloan Kettering Institute Postdocs (111)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (92)
  6. Human Oncology and Pathogenesis Program (83)

More Groups

People
  1. Kenneth Offit (35)
  2. Jedd Wolchok (30)
  3. Charles Rudin (28)
  4. Taha Merghoub (28)
  5. David Solit (20)
  6. Larry Norton (19)

More People

Years
  1. 2025 (9)
  2. 2024 (23)
  3. 2023 (19)
  4. 2022 (16)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Cancer Cell (95)
  2. Cell (44)
  3. American Journal of Human Genetics (33)
  4. Cell Reports (26)
  5. Cell Reports Medicine (11)
  6. Molecular Cell (11)

More Publications

Results (270)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
    Journal Article

    Taniguchi, H.; Caeser, R.; Chavan, S. S.; Zhan, Y. A.; Chow, A.; Manoj, P.; Uddin, F.; Kitai, H.; Qu, R.; Hayatt, O.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Optimizing the future: How mathematical models inform treatment schedules for cancer
    Review

    Mathur, D.; Barnett, E.; Scher, H. I.; Xavier, J. B.
    Trends in Cancer (2022)

    Fulltext@MSK | Save
  • Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
    Meeting Abstract

    He, C.; Maniyar, R. R.; Avraham, Y.; Zappasodi, R.; Rusinova, R.; Newman, W.; Heath, H.; Wolchok, J. D.; Dahan, R.; Merghoub, T.; more...
    Biophysical Journal (2022)

    Fulltext@MSK | Save
  • With one eye on the future
    Editorial

    Caldas, C.; Rescigno, M.; Turajlic, S.; Madabhushi, A.; Zhang, Z.; Lito, P.; Brown, C. E.; Pantel, K.; Haanen, J.; Duma, N.
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis
    Journal Article

    Han, H.; Wang, Y.; Curto, J.; Gurrapu, S.; Laudato, S.; Rumandla, A.; Chakraborty, G.; Wang, X.; Chen, H.; Jiang, Y.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types
    Journal Article

    Chhibber, A.; Huang, L.; Zhang, H.; Xu, J.; Cristescu, R.; Liu, X.; Mehrotra, D. V.; Shen, J.; Shaw, P. M.; Hellmann, M. D.; more...
    Immunity (2022)

    Fulltext@MSK | Save
  • MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
    Journal Article

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    iScience (2021)

    Fulltext@MSK | Save
  • Rejuvenating dysfunctional T cells in ovarian cancer: CD28 is the license to kill
    Editorial

    Uhlitz, F.; Zamarin, D.
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Liquid biopsies for residual disease and recurrence
    Review

    Wan, J. C. M.; Mughal, T. I.; Razavi, P.; Dawson, S. J.; Moss, E. L.; Govindan, R.; Tan, I. B.; Yap, Y. S.; Robinson, W. A.; Morris, C. D.; more...
    Med (2021)

    Fulltext@MSK | Save

    • Cell Press – authorized name for: